Search

Your search keyword '"Jankowski, Tomasz"' showing total 140 results

Search Constraints

Start Over You searched for: Author "Jankowski, Tomasz" Remove constraint Author: "Jankowski, Tomasz" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
140 results on '"Jankowski, Tomasz"'

Search Results

2. Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY

9. The relationship between self-esteem and self-compassion in socially anxious

21. Patient Experience and Wound Healing Outcomes Using Different Palatal Protection Methods After Free Gingival Grafts: A Systematic Review.

22. Unlocking the potential: the neutrophil-to-lymphocyte ratio (NLR) and the platelet-to-lymphocyte ratio (PLR) as biomarkers informing immunotherapy outcomes in lung cancer patients — single oncology center experience and literature review

25. Pembrolizumab-combination therapy for NSCLC- effectiveness and predictive factors in real-world practice

26. Polska adaptacja skróconej wersji Skali współczucia wobec siebie.

27. The Significance of Keratinized Mucosa in Implant Therapy: Narrative Literature Review and Case Report Presentation.

30. Dialogues between Distanced and Suffering I-Positions: Emotional Consequences and Self-Compassion.

32. Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis

33. Skeletal facial asymmetry: reliability of manual and artificial intelligence-driven analysis.

35. Abstract 4426: Removal of soluble TNF receptors as a novel form of immunotherapy for patients with advanced solid tumors

38. Supplementary Figure 1 from Quantitative Measurements of Tumoral p95HER2 Protein Expression in Metastatic Breast Cancer Patients Treated with Trastuzumab: Independent Validation of the p95HER2 Clinical Cutoff

39. Supplementary Figure 2 from Quantitative Measurements of Tumoral p95HER2 Protein Expression in Metastatic Breast Cancer Patients Treated with Trastuzumab: Independent Validation of the p95HER2 Clinical Cutoff

40. Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis

47. A high birefringence liquid crystal for lenses with large aperture

Catalog

Books, media, physical & digital resources